148
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Hypolipidemic effect of MeOH extract of Bambusae Caulis in Taeniam in hyperlipidemia induced by Triton WR-1339 and high cholesterol diet in rats

, , , &
Pages 439-445 | Received 18 Nov 2008, Accepted 22 Jan 2009, Published online: 21 Aug 2009

References

  • Ju, I., Jung, K., Ryu, J. Chemical components and physiological activities of bamboo (Phyllostachys bambusoides Starf) extracts prepared with different methods. Korean J Food Sci. Technol. 2005, 37, 542–548.
  • Shibata, M., Yamatake, Y., Sakamoto, M., Kanamori, M., Takagi, K. [Pharmacological studies on bamboo grass (1). Acute toxicity and anti-inflammatory and antiulcerogenic activities of water-soluble fraction(Folin) extracted from Sasa albomarginata Makino et Shibata]. Nippon Yakurigaku Zasshi. 1975, 71, 481–90.
  • Zhang, Y., Bao, B., Lu, B., Ren Y., Tie, X. Determination of flavone C-glucosides in antioxidant of bamboo leaves (AOB) fortified foods by reversed-phase high-performance liquid chromatography with ultraviolet diode array detection. J. Chromatogr. A. 2005, 1065, 177–85.
  • Suga, A., Takaishi, Y., Goto, S., Munakata, T., Yamauchi, I., Kogure, K. Two lignan dimers from bamboo stems (Phyllostachys edulis). Phytochemistry. 2003, 64, 991–6.
  • Jiao, J., Zhang, Y., Lou, D., Wu, X. Antihyperlipidemic and antihypertensive effect of a triterpenoid-rich extract from bamboo shavings and vasodilator effect of friedelin on phenylephrine-induced vasoconstriction in thoracic aortas of rats. Phytother. Res. 2007, 21, 1135–41.
  • Fiser, R. H., Jr., Denniston, J.C., Rindsig, R.B., Beisel, W. R. Triglyceride secretion rates: Use of Triton WR 1339 in the rhesus monkey. J. Nutr. 1974, 104, 223–6.
  • Kalopissis, A. D., Griglio, S., Malewiak, M.I., Rozen, R. Effect of a high-fat diet on rat very low density lipoprotein secretion. Biochim. Biophys. Acta. 1980, 620, 111–9.
  • Schurr, P. E., Schultz, J.R., Parkinson, T.M. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids. 1972, 7, 68–74.
  • Kwiterovich, P. O., Jr. The effect of dietary fat, antioxidants, and pro-oxidants on blood lipids, lipoproteins, and atherosclerosis. J. Am. Diet Assoc. 1997, 97, S31–41.
  • Yokozawa, T., Cho, E. J., Sasaki, S., Satoh, A., Okamoto, T., Sei, Y. The protective role of Chinese prescription Kangen-karyu extract on diet-induced hypercholesterolemia in rats. Biol. Pharm. Bull. 2006, 29, 760–5.
  • Zhang, H. W., Zhang, Y. H., Lu, M. J., Tong, W. J., Cao G.W. Comparison of hypertension, dyslipidemia and hyperglycaemia between buckwheat seed-consuming and non-consuming Mongolian-Chinese populations in Inner Mongolia, China. Clin. Exp. Pharmacol. Physiol. 2007, 34, 838–44.
  • Buege, J. A., Aust, S.D. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52, 302–10.
  • Yagi, K. Assay for blood plasma or serum, In Lipid Peroxides in Biology and Medicine. New York: Academic Press, 1982.
  • Brecher, P., Chan, C. T. Properties of acyl-CoA: Cholesterol O-acyltransferase in aortic microsomes from atherosclerotic rabbits. Biochim. Biophys. Acta 1980, 617, 458–71.
  • Lee, C. H., Jeong, T.S., Choi, Y.K., Hyun, B.H., Oh, G.T., Kim, E. H., Kim, J. R., Han, J. I., Bok, S. H. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem. Biophys. Res. Commun. 2001, 284, 681–8.
  • Hayashi, H., Shitara, M., Yamasaki, F. The origin of lipid accumulated in liver lysosomes after administration of triton WR-1339. J Biochem 1982, 92, 1585–90.
  • Wojcicki, J., Samochowiec, L., Hinek, A. The effect of cernitins on galactosamine-induced hepatic injury in rat. Arch. Immunol. Ther. Exp. (Warsz.) 1985, 33, 361–70.
  • Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B., Dawber, T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 1977, 62, 707–14.
  • Sacks, F. M., Pfeffer, M.A., Moye, L.A., Rouleau, J., Rutherford, J.D., Cole, T.G., Brown, L., Warnica, J.W., Arnold, M., Wun, C.C., Davis, B.R., Braunwald, E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N. Engl. J. Med. 1996, 335, 1001–9.
  • Gordon, D. J. & Rifkind, B. M. High-density lipoprotein—The clinical implications of recent studies. N. Engl. J. Med. 1989, 321, 1311–6.
  • Reichl, D., Miller, N.E. Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 1989, 9, 785–97.
  • The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet. 1994, 344, 1383–9.
  • Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane P.W., McKillop, J.H., Packard, C.J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 1995, 333, 1301–7.
  • Ohara, Y., Peterson, T. E., Sayegh, H. S., Subramanian, R. R., Wilcox, J. N., Harrison, D. G. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation. 1995, 92, 898–903.
  • Reilly, M. P., Pratico, D., Delanty, N., DiMinno, G., Tremoli, E.D., Rader Kapoor, S., Rokach, J., Lawson, J., FitzGerald, G. A. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation. 1998, 98, 2822–8.
  • Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C., Witztum, J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320, 915–24.
  • Diaz, M. N., Frei, B., Vita, J.A., Keaney, Jr., J.A. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 1997, 337, 408–16.
  • Regnstrom, J., Nilsson, J., Tornvall, P., Landou, C., Hamsten, A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 1992, 339, 1183–6.
  • Salonen, J. T., Yla-Herttuala, S., Yamamoto, R., Butler, S., Korpela, H., Salonen, R., Nyyssonen, K., Palinski, W., Witztum, J.L. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992, 339, 883–7.
  • Chang, J. D., Xu, Y., Raychowdhury, M. K., Ware, J. A. Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets. J. Biol. Chem. 1993, 268, 14208–14.
  • Chang, T. Y., Chang, C.C., Cheng, D. Acyl-coenzyme A: Cholesterol acyltransferase. Annu. Rev. Biochem. 1997, 66, 613–38.
  • Suckling, K. E., Stange E.F. Role of acyl-CoA: Cholesterol acyltransferase in cellular cholesterol metabolism. J. Lipid Res. 1985, 26, 647–71.
  • Accad, M., Smith S.J., Newland, D.L., Sanan, D.A., King, Jr., L. E., Linton, M.F., Fazio, S., Farese, Jr., R. V. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:Cholesterol acyltransferase 1. J. Clin. Invest. 2000, 105, 711–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.